YERUN Research Mobility Awards call 2021 is online

Yerun research mobility awards

Are you a researcher from a YERUN institution willing to collaborate with another researcher from another YERUN university? Then, this opportunity is for you!

The YERUN Research Mobility Awards (YRMAs) are competitive awards for early career researchers (PhD students and post-docs) equivalent to Euraxess Research Profiles R1 (up to the point of PhD) and R2 (PhD holders, post-doc or equivalent who are not yet fully independent or until 8 years since completion of PhD) from YERUN Universities.

This year, the programme will support researchers to establish a new research collaboration in a virtual format. The programme provides a platform to:

  • work with other YERUN academics on a research project, publication, or new collaborative activity;
  • promote multidisciplinary research across the YERUN network;
  • enrich the research and training opportunities for PhD students, early career and postdoctoral scholars within the YERUN network.

A YERUN Research Mobility Award provides a flat-rate award to cover your expenses related to establishing a virtual collaboration (1,000 Euros) (please note that this amount may be subject to tax withholding). Examples of activities whose cost can be covered by the grant are:

  • Publication in an Open Access journal;
  • Organisation of a virtual conference;
  • Participation fees in a virtual conference;
  • Purchase of a digital tool/ software that can support the virtual collaboration;
  • Consumables equipment;
  • Shipping of samples and other lab material;
  • any other idea you might have!

The research collaboration has to be established and implemented during the year 2021. You will not have to provide any receipts and it is your responsibility to arrange the activities related to your collaboration.


  • You must be a Researchers R1 (up to the point of PhD) and R2 (PhD holders, post-doc or equivalent who are not yet fully independent or until 8 years since completion of PhD) from YERUN Universities Researchers from institutions that are not YERUN members are not eligible.
  • Researcher Mobility Awards will only be used for collaborations with YERUN institutions located in a country different from the one of your home institution.
  • You must agree to submit a report on the outcomes at the end of your collaboration and a follow-up report describing any subsequent research collaborations with YERUN partners no later than one year after the award. This information will be used for YERUN Communication and Evaluation activities.
  • All applications must be submitted with a letter of support signed by the hosting department. If no letter is provided with your application, your application will be rejected.
  • Researchers that have been previously awarded a YRMA are not eligible to re-apply.

If you are interested in applying, please read the 2021 Call and apply online (link below). You can check in this document the different sections of the application.

If you want to read successful stories from the previous editions, click here.

🛑 Deadline for applications: 12 May 2021 (EOB).

Important links:

Sustainable Public Procurement Project SAPIENS Network Awarded €3.9 million by EU Research Agency


The Project SAPIENS (Sustainability and Procurement in International, European, and National Systems) has been awarded a Horizon 2020 Marie Skłodowska-Curie Actions Innovative Training Network (ITN) grant of €3.9 million by the European Research Agency (European Commission).

The SAPIENS combines 10 international Universities from eight countries, and non-academic partners in seven countries. At the heart of the project are 15 Ph.D. positions on various multidisciplinary aspects of Sustainable Public Procurement linked to the achievement of the Sustainable Development Goals.

Call for Ph.D Applications

The 15 Ph.D. students, one of which will be based in Rome under the supervision of Prof. Gustavo Piga and Prof. Andrea Appolloni, will attend a common training programme, participate in common public engagement, dissemination and impact activities, and benefit from a number of relevant placements in public institutions, think tanks, lobbyists, and international organisations.

The ESR will work within Tor  Vergata’s School of Economics  and will be enrolled in the Ph.D. in Management working on the research project ESR2 “Developing sustainable and procurement solutions at global level (bottom up approach)”

The project will not only offer extraordinary global research and training opportunities to 15 Early Stage Researchers, but will also contribute to increasing the overall quality and innovation of doctoral training in Europe and beyond. The aim is to produce significant research results in law, economics, business studies and social science, make them openly available, facilitate the utilisation of that knowledge by policymakers, think tanks, business, and the legal and other professions, and to train a uniquely qualified cohort with professional prospects inside but also beyond academia.

The project will run from 2021 to 2025 and will be managed from the University of Turin, University of Birmingham, University of Copenhagen, Lodz University of Technology, Corvinus University of Budapest , Tor Vergata University of Rome, Hasselt University, University of Gävle, Babes-Bolyai University in Cluj Napoca, and the University of Greenwich. Moreover, 18 partners, including the European Bank for Reconstruction and Development, the International Training Centre of the International Labour Organisation, George Washington University, Federation of Small Businesses, Fair Trade Advocacy Group, Stichting Fair Trade Advocacy Office, Eating City, as well as national agencies, public purchasers and lobbyists are contributing to the training programme.

Info and Deadline

Deadline: *25 April 16 May 2021 at 12 pm (*postponed)

30 post-doc scholarships at YUFE’s Carlos III University of Madrid

30 post-doc scholarships at YUFE's Carlos III

The Universidad Carlos III de Madrid seeks young and talented research and teaching staff. Thus the UC3M is delighted to launch this call aimed at postdoctoral candidates who have obtained a doctorate degree at another university, no more than six years ago. This call provides successful candidates a competitive salary, as well as the possibility to join an experienced UC3M team and develop their research and teaching skills.

The deadline for application is March 21, 2021.

Parkinson’s disease: Research identifies a potential biomarker

parkinsons disease research

For the first time, a team of researchers has shown a significant increase in the chemokine prokineticin 2 (PK2), a chemokine-like peptide, in the serum of patients with Parkinson’s disease. The results of this pilot study conducted by Cinzia Severini of the Institute of Biochemistry and Cell Biology of the National Research Council (Cnr-Ibbc), by Nicola Biagio Mercuri and Tommaso Schirinzi of the Neurological Clinic of the University of Rome Tor Vergata and by Roberta Lattanzi and Daniela Maftei from the Department of Physiology and Pharmacology of the Sapienza University of Rome have been published in Movement Disorders.

The study analyzed the blood of 31 patients with Parkinson’s disease and for the first time it was shown that serum levels of PK2 are significantly increased compared to healthy control subjects.

Cinzia Severini researcher of the CNR-Ibbc explains:

PK2 is abundantly present in the central nervous system and is involved in various physiological and pathological functions including neuroinflammation. Experimental evidence has previously shown that PK2 is a factor that is activated early in nigrostriatal degeneration associated with Parkinson’s disease, suggesting its neuroprotective role through an action to restore mitochondrial damage.”

“The correlation between the increase in PK2 in serum and two markers of neurodegeneration in the cerebrospinal fluid (CSF or CSF) of the same patients was particularly interesting, such as the beta amyloid1-42 protein and lactate. In particular, the increase in serum of PK2, associated with the higher levels of beta amyloid1-42 found in the CSF, may indicate a protective effect of this chemokine against the pathology at the level of neuronal synapses and the deposition of plaques of amyloid, common events in both Parkinson’s disease and Alzheimer’s disease.”

“Furthermore, this increase in PK2 correlates with the decrease in lactate levels in the CSF, an index of oxidative stress and mitochondrial damage, confirming the hypothesis of an antioxidant action and restoration of mitochondrial damage “.

These results suggest that PK2 may represent not only a potential early biomarker of the disease, but also a pharmacological target for the creation of potentially useful therapies in Parkinson’s disease.

“These encouraging preliminary data now need to be confirmed in a larger study, including a larger and heterogeneous sample of patients, and to evaluate additional biological tissues. The ultimate goal is to fully understand the role of PK2 in Parkinson’s disease, thus opening the way to possible clinical developments centered on this peptide “, concludes Severini.

Original Article: